620 filings
Page 7 of 31
8-K
4wfy s5ja2qmj0
6 Aug 20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
2:45pm
8-K
zyt9feh c7
30 Jul 20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
9:42am
8-K
ccxdk409wvdgq oqk0b
21 Jul 20
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
9:25am
8-K
iip2qhlv
8 Jul 20
Other Events
9:31am
8-K
xkg45wdyyui9nuq
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
x3wytfpgf5ad0y54
25 Jun 20
Other Events
10:00am
8-K
w0g04d zgshabsw
18 Jun 20
JanOne Launches Strategic Alternatives Process for Legacy Businesses
9:38am
SC 13G
mjapoys
18 May 20
JanOne / Energy Efficiency Investments ownership change
5:12pm
8-K
xqocyodm7zj8unp
4 May 20
Entry into a Material Definitive Agreement
4:46pm
8-K/A
fq7gpbs
23 Apr 20
Departure of Directors or Certain Officers
6:05am
8-K
4nwa62cn1aar n5
22 Apr 20
Departure of Directors or Certain Officers
4:30pm
NT 10-K
prod58j
30 Mar 20
Notice of late annual filing
12:00am
8-K
y6wpssu v554a2u
7 Feb 20
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
12:00am
8-K
5phe0pvsnlu
10 Jan 20
Departure of Directors or Certain Officers
5:00pm
3
itw07 hl1gn1g98zgjm8
10 Jan 20
JanOne / John Bitar ownership change
5:00pm
8-K
yf0q 6xms5uvjwd9g8
3 Dec 19
JanOne Names Tony Giordano, Ph.D., as Chief Scientific Officer
9:00am
8-K
kivzcc rxhgp28
25 Nov 19
JanOne Acquires Worldwide, Exclusive License
8:00am